These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 17678433

  • 1. An update on the management of Chagas cardiomyopathy.
    Rocha MO, Teixeira MM, Ribeiro AL.
    Expert Rev Anti Infect Ther; 2007 Aug; 5(4):727-43. PubMed ID: 17678433
    [Abstract] [Full Text] [Related]

  • 2. Clinical management of chronic Chagas cardiomyopathy.
    Rocha MO, Ribeiro AL, Teixeira MM.
    Front Biosci; 2003 Jan 01; 8():e44-54. PubMed ID: 12456332
    [Abstract] [Full Text] [Related]

  • 3. Neglected tropical cardiomyopathies: I. Chagas disease: myocardial disease.
    Yacoub S, Mocumbi AO, Yacoub MH.
    Heart; 2008 Feb 01; 94(2):244-8. PubMed ID: 18195131
    [No Abstract] [Full Text] [Related]

  • 4. Chagas cardiomyopathy--where do we stand after a hundred years?
    Biolo A, Ribeiro AL, Clausell N.
    Prog Cardiovasc Dis; 2010 Feb 01; 52(4):300-16. PubMed ID: 20109600
    [Abstract] [Full Text] [Related]

  • 5. Clinical aspects of the Chagas' heart disease.
    Punukollu G, Gowda RM, Khan IA, Navarro VS, Vasavada BC.
    Int J Cardiol; 2007 Feb 14; 115(3):279-83. PubMed ID: 16769134
    [Abstract] [Full Text] [Related]

  • 6. [Chagas' disease and ischemic stroke].
    Carod-Artal FJ.
    Neurologia; 2006 Apr 14; 21(3):135-49. PubMed ID: 16575627
    [Abstract] [Full Text] [Related]

  • 7. [Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic].
    Gascón J, Albajar P, Cañas E, Flores M, Gómez i Prat J, Herrera RN, Lafuente CA, Luciardi HL, Moncayo A, Molina L, Muñoz J, Puente S, Sanz G, Treviño B, Sergio-Salles X.
    Rev Esp Cardiol; 2007 Mar 14; 60(3):285-93. PubMed ID: 17394874
    [Abstract] [Full Text] [Related]

  • 8. The role of parasite persistence in pathogenesis of Chagas heart disease.
    Gutierrez FR, Guedes PM, Gazzinelli RT, Silva JS.
    Parasite Immunol; 2009 Nov 14; 31(11):673-85. PubMed ID: 19825107
    [Abstract] [Full Text] [Related]

  • 9. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).
    Marin-Neto JA, Rassi A, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, Rosas F, Yusuf S, BENEFIT Investigators.
    Am Heart J; 2008 Jul 14; 156(1):37-43. PubMed ID: 18585495
    [Abstract] [Full Text] [Related]

  • 10. Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy.
    Muratore CA, Baranchuk A.
    Vasc Health Risk Manag; 2010 Aug 09; 6():593-601. PubMed ID: 20730015
    [Abstract] [Full Text] [Related]

  • 11. [Cardiac complications of American trypanosomiasis (Chagas disease). Various case reports and general observations].
    Liechti M, Baur HR, Gurtner HP, Straub PW.
    Schweiz Med Wochenschr; 1990 Oct 13; 120(41):1493-6. PubMed ID: 2237336
    [Abstract] [Full Text] [Related]

  • 12. Perspectives in Chagas disease treatment.
    Oliveira GB, Avezum Á, Cordeiro Mattos AJ.
    Glob Heart; 2015 Sep 13; 10(3):189-92. PubMed ID: 26407515
    [No Abstract] [Full Text] [Related]

  • 13. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association.
    Nunes MCP, Beaton A, Acquatella H, Bern C, Bolger AF, Echeverría LE, Dutra WO, Gascon J, Morillo CA, Oliveira-Filho J, Ribeiro ALP, Marin-Neto JA, American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Stroke Council.
    Circulation; 2018 Sep 18; 138(12):e169-e209. PubMed ID: 30354432
    [Abstract] [Full Text] [Related]

  • 14. Acute chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: a case report.
    Souza FF, Castro-E-Silva O, Marin Neto JA, Sankarankutty AK, Teixeira AC, Martinelli AL, Gaspar GG, Melo L, Figueiredo JF, Romano MM, Maciel BC, Passos AD, Rossi MA.
    Transplant Proc; 2008 Apr 18; 40(3):875-8. PubMed ID: 18455041
    [Abstract] [Full Text] [Related]

  • 15. Chagas disease as a cause of heart failure and ventricular arrhythmias in patients long removed from endemic areas: an emerging problem in Europe.
    Vannucchi V, Tomberli B, Zammarchi L, Fornaro A, Castelli G, Pieralli F, Berni A, Yacoub S, Bartoloni A, Olivotto I.
    J Cardiovasc Med (Hagerstown); 2015 Dec 18; 16(12):817-23. PubMed ID: 25022923
    [Abstract] [Full Text] [Related]

  • 16. Chagas cardiomyopathy and heart failure: From epidemiology to treatment.
    Santos É, Menezes Falcão L.
    Rev Port Cardiol (Engl Ed); 2020 May 18; 39(5):279-289. PubMed ID: 32532535
    [Abstract] [Full Text] [Related]

  • 17. Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America.
    Muratore CA, Batista Sa LA, Chiale PA, Eloy R, Tentori MC, Escudero J, Lima AM, Medina LE, Garillo R, Maloney J.
    Europace; 2009 Feb 18; 11(2):164-8. PubMed ID: 19056745
    [Abstract] [Full Text] [Related]

  • 18. Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment.
    Bocchi EA, Bestetti RB, Scanavacca MI, Cunha Neto E, Issa VS.
    J Am Coll Cardiol; 2017 Sep 19; 70(12):1510-1524. PubMed ID: 28911515
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chagas' heart disease in Europe: an emergent disease?
    Dobarro D, Gomez-Rubin C, Sanchez-Recalde A, Olias F, Bret-Zurita M, Cuesta-Lopez E, Robles-Marhuenda A, Fraile-Vicente JM, Paño-Pardo JR, Lopez-Sendon J.
    J Cardiovasc Med (Hagerstown); 2008 Dec 19; 9(12):1263-7. PubMed ID: 19001935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.